A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
about
Mode of administration of dulaglutide: implications for treatment adherenceCardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular eventsGastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.Albiglutide: a unique GLP-1 receptor agonist.The safety of albiglutide for the treatment of type 2 diabetes.Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.
P2860
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@ast
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@en
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@nl
type
label
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@ast
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@en
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@nl
prefLabel
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@ast
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@en
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@nl
P2093
P2860
P3181
P356
P1476
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
@en
P2093
Deepson S Shyangdan
Joseph Paul O'Hare
Norman Waugh
Tara Gurung
P2860
P304
P3181
P356
10.2147/DMSO.S34418
P407
P577
2015-01-01T00:00:00Z